Novo Nordisk Market Cap

Novo Nordisk has a market cap or net worth of $305.46 billion as of March 31, 2025. Its market cap has decreased by -48.90% in one year.

Market Cap

305.46B

Enterprise Value

316.57B

Revenue

40.31B

Ranking

n/a

PE Ratio

21.79

Stock Price

$69.50

Market Cap Chart

Since February 18, 1997, Novo Nordisk's market cap has increased from 7.15B to 305.46B, an increase of 4,174.31%. That is a compound annual growth rate of 14.29%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	305.46B	-20.83%
Dec 30, 2024	385.82B	-16.41%
Dec 29, 2023	461.55B	51.61%
Dec 30, 2022	304.43B	19.34%
Dec 30, 2021	255.09B	56.58%
Dec 30, 2020	162.91B	19.30%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.82B
SS Innovations International	1.76B
Nika Pharmaceuticals	1.02B
Veradigm	720.71M
Elite Pharmaceuticals	470.04M
Glass House Brands	371.89M
Northwest Biotherapeutics	318.00M
CytoDyn	288.56M

Market Cap Rankings